MNST

Monster Beverage Corporation

$72.37

-0.55%
Apr 2, 2026
Bobby Quantitative Model
Monster Beverage Corporation is a leader in the energy drink category within the non-alcoholic beverage market. It is defined by its dominant Monster Energy brand portfolio and benefits from a strategic global distribution partnership with Coca-Cola.

People also watch

Coca-Cola Company

Coca-Cola Company

KO

Analysis
PepsiCo, Inc.

PepsiCo, Inc.

PEP

Analysis
Keurig Dr Pepper Inc.

Keurig Dr Pepper Inc.

KDP

Analysis
Coca-Cola Consolidated, Inc. Common Stock

Coca-Cola Consolidated, Inc. Common Stock

COKE

Analysis
Celsius Holdings, Inc. Common Stock

Celsius Holdings, Inc. Common Stock

CELH

Analysis

BobbyInvestment Opinion: Should I buy MNST Today?

Based on a comprehensive synthesis of the data, the objective assessment is a Hold. The company's underlying business is exceptionally strong, with impressive growth, profitability, and a pristine balance sheet. However, the current premium valuation (P/E of 39.3) and recent underperformance suggest the stock is fairly valued to slightly overvalued in the near term. Investors may find better entry points during market pullbacks. The bullish analyst consensus supports a long-term positive view, but immediate upside appears limited.

Sign up to view all

MNST 12-Month Price Forecast

The analysis yields a neutral stance with medium confidence. The exceptional quality of the business is undeniable, but the price appears to reflect most of the near-term optimism. The path of least resistance is likely range-bound consolidation, with the base case being the most probable outcome over the next 12 months.

Historical Price
Current Price $72.37
Average Target $80
High Target $95
Low Target $60

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Monster Beverage Corporation's 12-month outlook, with a consensus price target around $94.08 and implied upside of +30.0% versus the current price.

Average Target

$94.08

13 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

13

covering this stock

Price Range

$58 - $94

Analyst target range

Buy
3 (23%)
Hold
6 (46%)
Sell
4 (31%)

Wall Street analysts maintain a generally bullish consensus on Monster Beverage, with recent actions from firms like Deutsche Bank, Wells Fargo, and Morgan Stanley reiterating Buy or Overweight ratings. The coverage is substantial, with 13 analysts providing estimates. They forecast an average EPS of $3.66 for the period in view, with a high estimate of $3.85 and a low of $3.47. A specific consensus target price is not provided in the data.

Drowning in data?

Find the real signal!

Bulls vs Bears: MNST Investment Factors

Monster Beverage presents a compelling mix of strong fundamentals and premium valuation. Its robust growth, profitability, and fortress balance sheet are offset by a high valuation and recent technical weakness. The stock's near-term trajectory will likely depend on its ability to justify its premium multiples with sustained earnings growth.

Bullish

  • Strong Revenue Growth: Q4 2025 revenue grew 17.6% YoY, showing robust demand.
  • Exceptional Financial Health: Zero debt, high current ratio of 3.7, and strong free cash flow.
  • High Profitability Margins: Net margin of 23.0% and operating margin of 29.2% are industry-leading.
  • Analyst Bullish Consensus: 13 analysts maintain Buy/Overweight ratings, forecasting EPS growth.

Bearish

  • Premium Valuation: Trailing P/E of 39.3 and P/S of 9.0 are high, limiting upside.
  • Recent Price Weakness: Stock down 15% over past month, underperforming the S&P 500.
  • High Short Interest: Short ratio of 3.42 indicates significant market skepticism.
  • Sector Competition & Regulation: Energy drink market faces intense competition and potential regulatory scrutiny.

MNST Technical Analysis

The stock's overall trend over the past six months has been positive, with a 7.22% gain, significantly outperforming the S&P 500's -2.82% return. The price climbed from around $67.58 in early October 2025 to a peak of $86.66 in late February 2026. However, recent short-term performance has been weak, with the stock down 15.05% over the past month and 5.49% over the past three months, underperforming the broader market during these periods. The current price of $72.46 is near the lower end of its 52-week range of $54.73 to $87.38, representing a retreat from the recent highs and placing it approximately 17% below its 52-week peak.

Beta

0.44

0.44x market volatility

Max Drawdown

-17.7%

Largest decline past year

52-Week Range

$55-$87

Price range past year

Annual Return

+21.9%

Cumulative gain past year

PeriodMNST ReturnS&P 500
1m-8.4%-3.6%
3m-5.0%-4.0%
6m+7.7%-2.0%
1y+21.9%+16.2%
ytd-5.0%-3.8%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

MNST Fundamental Analysis

Revenue growth remains robust, with Q4 2025 revenue of $2.13 billion representing a 17.61% year-over-year increase. Profitability is strong, with a net margin of 23.0% for the quarter, consistent with the trailing twelve-month operating margin of 29.2%. The company maintains an exceptionally strong financial position with zero debt, a high current ratio of 3.70, and substantial free cash flow of nearly $2 billion over the trailing twelve months. Operational efficiency is highlighted by a high return on equity of 23.1% and a return on assets of 18.0%, indicating effective use of shareholder capital and company assets.

Quarterly Revenue

$2.1B

2025-12

Revenue YoY Growth

+0.17%

YoY Comparison

Gross Margin

+0.55%

Latest Quarter

Free Cash Flow

$2.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Open an Account, get $2 TSLA now!

Valuation Analysis: Is MNST Overvalued?

Given the company's positive and substantial net income, the primary valuation metric is the trailing P/E ratio, which stands at 39.3. This is elevated, reflecting a premium valuation for the company's growth and profitability profile. The forward P/E of 28.4 is lower, suggesting anticipated earnings growth. The price-to-sales ratio of 9.02 and EV/EBITDA of 27.9 further confirm a premium valuation level relative to absolute earnings and cash flow generation. Data for a direct peer comparison with industry averages is not available in the provided inputs.

PE

39.3x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range 30x~47x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

27.9x

Enterprise Value Multiple

Investment Risk Disclosure

The primary risk for MNST is its elevated valuation. A trailing P/E of 39.3 and EV/EBITDA of 27.9 leave little room for error; any earnings disappointment or growth deceleration could trigger a significant multiple contraction, as suggested by the recent 15% monthly decline. The high short ratio of 3.42 reflects substantial market skepticism regarding its valuation sustainability.

Operational risks include intense competition in the global energy drink market and potential regulatory headwinds concerning product ingredients or marketing. Furthermore, while the Coca-Cola partnership is a major strength, it also creates a degree of dependency. The company's geographic revenue concentration (two-thirds from the US and Canada) exposes it to regional economic or consumer sentiment shifts, though this is mitigated by its strong brand and distribution.

FAQ

The key risk is valuation compression. If growth slows, the high P/E of 39.3 could contract sharply. Other risks include intense competition in energy drinks, potential regulatory changes, and high short interest (short ratio 3.42) which can amplify downward moves. Geographic concentration in North America is also a minor risk.

The 12-month outlook is for range-bound movement with a slight upward bias. The base case (60% probability) sees a target range of $75-$85, as the company grows into its valuation. The bull case targets $85+, while the bear case could see a retest toward $60 if growth disappoints. Analysts are bullish, forecasting average EPS of $3.66.

MNST appears fairly valued to slightly overvalued based on traditional metrics. Its trailing P/E of 39.3 and price-to-sales of 9.0 command a significant premium, justified by its high growth and profitability. The forward P/E of 28.4, based on analyst EPS estimates, offers a more reasonable outlook, but still represents a premium valuation.

MNST is a stock to hold, not aggressively buy at current levels. It is a fantastic company with 17.6% revenue growth, 23% net margins, and no debt. However, its trailing P/E of 39.3 is high, suggesting much of this quality is already priced in. Investors should consider waiting for a pullback to build a position.

MNST is better suited for long-term investors. Its strong market position, partnership with Coca-Cola, and excellent financials make it a durable compounder. Short-term trading is challenged by the stock's premium valuation and volatility, as seen in its 15% drop over the past month. Patience is required to realize its long-term growth potential.